Top-News

Merck KGaA ADR News

Keine aktuellen Kursdaten verfügbar
WKN: A0RFD1
ISIN: US5893391004
Typ: Aktie

Merck KGaA ADR News

21.07.17 - PR Newswire
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma PR Newswire
29.06.17 - PR Newswire
Merck erweitert Kapazitäten am Schweizer Biotech-Produktionsstandort Aubonne
Merck erweitert Kapazitäten am Schweizer Biotech-​Produktionsstandort Aubonne PR Newswire
29.06.17 - PR Newswire
Merck Expands Packaging Capacity at Swiss Biotech Manufacturing Site of Aubonne
Merck Expands Packaging Capacity at Swiss Biotech Manufacturing Site of Aubonne PR Newswire
26.06.17 - PR Newswire
Data Provide Additional Insight Into the Mode of Action of MAVENCLAD™ (Cladribine Tablets) in Patients With Relapsing MS
Data Provide Additional Insight Into the Mode of Action of MAVENCLAD™ (Cladribine Tablets) in Patients With Relapsing MS PR Newswire
24.06.17 - PR Newswire
Merck to Present Data on MAVENCLAD™ (Cladribine Tablets) and Rebif® (interferon beta-1a) in Patients with Relapsing MS at EAN Congress 2017
Merck to Present Data on MAVENCLAD™ (Cladribine Tablets) and Rebif® (interferon beta-1a) in Patients with Relapsing MS at EAN Congress 2017 PR Newswire
23.06.17 - PR Newswire
Cladribine Tablets Receives Positive CHMP Opinion for Treatment of Relapsing Forms of Multiple Sclerosis
Cladribine Tablets Receives Positive CHMP Opinion for Treatment of Relapsing Forms of Multiple Sclerosis PR Newswire
31.05.17 - PR Newswire
Merck Honors World MS Day by Launching Care Partner Survey with IACO
Merck Honors World MS Day by Launching Care Partner Survey with IACO PR Newswire
22.05.17 - PR Newswire
Aufklärungskampagne zu Symptomen von Schilddrüsenerkrankungen gestartet - Motto: "Es liegt nicht an Ihnen. Es ist Ihre Schilddrüse."
Aufklärungskampagne zu Symptomen von Schilddrüsenerkrankungen gestartet - Motto: "Es liegt nicht an Ihnen. Es ist Ihre Schilddrüse." PR Newswire
22.05.17 - PR Newswire
‘It’s not you. It’s your thyroid.’ Campaign Launched to Raise Awareness of Symptoms
‘It’s not you. It’s your thyroid.’ Campaign Launched to Raise Awareness of Symptoms PR Newswire
19.05.17 - PR Newswire
100 Healthy Years - Are Kids Prepared?
100 Healthy Years - Are Kids Prepared? PR Newswire
19.05.17 - PR Newswire
100 Healthy Years - Are Kids Prepared?
100 Healthy Years - Are Kids Prepared? PR Newswire
19.05.17 - PR Newswire
100 Jahre alt werden bei guter Gesundheit - sind unsere Kinder darauf vorbereitet?
100 Jahre alt werden bei guter Gesundheit - sind unsere Kinder darauf vorbereitet? PR Newswire
17.05.17 - PR Newswire
Shaping Cancer Care Today and Tomorrow: Merck, KGaA, Darmstadt, Germany, to Present New Data from Rapidly Evolving Pipeline at ASCO 2017
Shaping Cancer Care Today and Tomorrow: Merck, KGaA, Darmstadt, Germany, to Present New Data from Rapidly Evolving Pipeline at ASCO 2017 PR Newswire
17.05.17 - PR Newswire
Shaping Cancer Care Today and Tomorrow: Merck to Present New Data from Rapidly Evolving Pipeline at ASCO 2017
Shaping Cancer Care Today and Tomorrow: Merck to Present New Data from Rapidly Evolving Pipeline at ASCO 2017 PR Newswire
17.05.17 - PR Newswire
Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data Highlighting Potential of Avelumab in Challenging Cancers at ASCO 2017
Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data Highlighting Potential of Avelumab in Challenging Cancers at ASCO 2017 PR Newswire
17.05.17 - PR Newswire
Merck erhält Indikationserweiterung für Glucophage® SR bei Patienten mit hohem Risiko für Typ-2-Diabetes in Großbritannien
Merck erhält Indikationserweiterung für Glucophage® SR bei Patienten mit hohem Risiko für Typ-2-Diabetes in Großbritannien PR Newswire
17.05.17 - PR Newswire
Merck's Glucophage® SR Receives Label Extension for Patients at High Risk of Type 2 Diabetes in the UK
Merck's Glucophage® SR Receives Label Extension for Patients at High Risk of Type 2 Diabetes in the UK PR Newswire
10.05.17 - PR Newswire
European Commission Grants Approval for Merck's New Pergoveris® Pen for Fertility Treatment
European Commission Grants Approval for Merck's New Pergoveris® Pen for Fertility Treatment PR Newswire
28.04.17 - PR Newswire
Investigational Cladribine Tablets Data Show Greater Treatment Effect in Relapsing MS Patients at a Higher Risk of Disease Progression
Investigational Cladribine Tablets Data Show Greater Treatment Effect in Relapsing MS Patients at a Higher Risk of Disease Progression PR Newswire
21.04.17 - PR Newswire
Merck to Present Rebif® (interferon beta-1a) and Investigational Cladribine Tablets Data at AAN 2017
Merck to Present Rebif® (interferon beta-1a) and Investigational Cladribine Tablets Data at AAN 2017 PR Newswire

Newssuche

Videos

newspaper
08:40 Uhr +6,31%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »